Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalicylic Acid in Fixed-Dose Combination with Clopidogrel Versus Enteric Aspirin in Chinese Subjects Under Fasting Conditions: A Phase 1, Open-Label, Randomized, Crossover Study

INTRODUCTION: Dual antiplatelet therapy, aspirin and a P2Y(12) inhibitor, is recommended to prevent thrombotic complications of acute coronary syndrome. Clopidogrel plus acetylsalicylic acid combination is the most commonly used dual antiplatelet therapy recommended by international guidelines and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lu, Di, Yujing, Guo, Tingting, Ming, Jeffrey E., Kong, Fangyuan, Yin, Huiqiu, Zhang, Linlin, Xie, Fang, Yang, Na, Ping, Chuan, Li, Yi, Hou, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467447/
https://www.ncbi.nlm.nih.gov/pubmed/32418143
http://dx.doi.org/10.1007/s12325-020-01369-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467447/
https://www.ncbi.nlm.nih.gov/pubmed/32418143
http://dx.doi.org/10.1007/s12325-020-01369-z

Ejemplares similares